In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act.

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

CVS Caremark, CVS Health’s (NYSE:CVS) pharmacy benefit manager, has been ordered by a federal judge to pay $289.9M in damages ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

Notably, the case came from a whistleblower lawsuit filed by Sarah Behnke, a former Medicare Part D actuary at Aetna, who claimed that CVS Caremark caused insurers like Aetna to submit inflated drug ...

A federal judge has ordered CVS Health's PBM Caremark to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more than a decade ago.

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.

In April it closed its $1.25 billion acquisition of Medicare Part D company Universal American, a move that added 1.9 Part D members and more than doubled the company's Part D membership to 3.1 ...

CVS Caremark is striving to acquire a leading position in the Medicare Prescription Drug Plan business in the U.S. It aggressively grew its Pharmacy Benefits Management business in 2011, winning ...